Table 3.
Disease subgroup | Number of patients | Mean number of visits* | NCD medication cost (US$) |
Disease-specific consumables (US$) |
Shared consumables (US$) | Laboratories (US$) | Operating cost (US$)† | Total per-patient cost (US$) |
Diabetes mellitus | 91 | 6.5 | 57.60 | 0 | 2.03 | 15.89 | 75.80 | 151.32 |
On Insulin | 44 | |||||||
Congestive heart failure | 204 | 5.3 | 18.09 | 0.09 | 2.03 | 8.45 | 75.80 | 104.47 |
None/unknown | 71 | |||||||
NYHA I–II | 65 | |||||||
NYHA III–IV | 68 | |||||||
Chronic respiratory disease |
114 | 3 | 8.51 | 0.09 | 2.03 | 0 | 58.66 | 69.30 |
None/unknown | 72 | |||||||
Mild intermittent/persistent | 22 | |||||||
Moderate–severe persistent | 20 | |||||||
Hypertension | 223 | 2.7 | 6.80 | 0 | 2.03 | 5.95 | 58.66 | 73.44 |
None/unknown | 76 | |||||||
Stage I–II | 134 | |||||||
Stage III–IV | 13 | |||||||
Total | 632 |
*Per fiscal year of 2014.
†Operating cost excluding medication cost, consumables and laboratories. Consultant cost only applied to patients with congestive heart failure and type 2 diabetes mellitus.
NCD, non-communicable disease; NYHA, New York Heart Association.